Products/Services Used | Details | Operation |
---|---|---|
Catalog Antibody> | Peg3 antibody was custom made at Genscript. Treatment of PAER2BECN1.luc with the mTOR inhibitor, Torin 1 was used as a positive control. I, BECN1 promoter was synthesized by GenScript, incorporating nucleotide base changes 5’-TGGCT-3’ to 5’-TAACC-3’ of the putative Peg3 binding site. | Get A Quote |
We previously discovered that systemic delivery of decorin for treatment of breast carcinoma xenografts induces paternally expressed gene 3 (Peg3), an imprinted gene encoding a zinc finger transcription factor postulated to function as a tumor suppressor. Here we found that expression of Peg3 increased Beclin 1 promoter activity and protein expression. This process required the full-length Peg3 as truncated mutants lacking either the N-terminal SCAN domain or the zinc fingers failed to translocate to the nucleus and promote Beclin 1 transcription. Importantly, overexpression of Peg3 in endothelial cells stimulated autophagy and concurrently inhibited endothelial cell migration and evasion from a 3D matrix.... More